(Q61863535)

English

Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis

scientific article published in October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

Madelon M Maurice

1

object named as

Madelon M. Maurice

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

5

object named as

René A. W. van Lier

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Wiebo L. Van Der Graaff

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Angela Leow

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Ferdinand C. Breedveld

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Cornelis L. Verweij

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

October 1999

0 references

1 October 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Arthritis and Rheumatism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

42

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

2166-2173

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Interleukin-2 diphtheria fusion protein (DAB486IL-2) in refractory rheumatoid arthritis. A double-blind, placebo-controlled trial with open-label extension.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Humanised monoclonal antibody therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term followup of CD4+ T cell counts

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Cytokine expression in chronic inflammatory disease

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

A functional dichotomy in CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Human TH1 and TH2 subsets: doubt no more

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Acquisition of lymphokine-producing phenotype by CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

The Th1/Th2 balance in autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Th1 and Th2 cells in autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Detection of intracellular cytokines by flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

The CD27- subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Phenotypic and functional separation of memory and effector human CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Divergent T-cell cytokine patterns in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Expression of the Activation Antigen CD27 in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Enrichment of differentiated CD45RBdim,CD27- memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

The inverse association between tuberculin responses and atopic disorder.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199910%2942%3A10%3C2166%3A%3AAID-ANR18%3E3.0.CO%3B2-K

21 January 2018

Identifiers

10.1002/1529-0131(199910)42:10<2166::AID-ANR18>3.0.CO;2-K

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10524689%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61863535&oldid=1536769773"